2 citations
,
September 2021 This review discusses the role of teledermatology during the COVID-19 pandemic, highlighting the practical challenges and opportunities in diagnosing skin diseases in low-income countries, and reports no new clinical results.
2 citations
,
March 2021 in “Journal of Pakistan Association of Dermatologists” This study found that a lack of knowledge about alopecia areata, compounded by low literacy, can lead to improper treatment and increased stress among affected individuals.
1 citations
,
May 2025 in “Natural Products and Bioprospecting” In this study, PEVIII, a nanocomposite chitosan-coated vesicle containing both α-hederin and hederacoside C, demonstrated notable antibacterial activity against Pseudomonas aeruginosa in a keratitis model, showing significant lesion reduction, tissue improvement, and decreased bacterial load and inflammatory markers compared to other treatments.
1 citations
,
November 2024 in “Expert Opinion on Drug Safety” In this retrospective pharmacovigilance study, researchers analyzed over 7,900 adverse event reports related to aromatase inhibitors, identifying common side effects and toxicological mechanisms to highlight potential safety concerns in treating postmenopausal hormone receptor-positive breast cancer.
1 citations
,
December 2022 in “BMC Public Health” In this study, among over one million COVID-19 patients, several long-term effects were identified, with age and gender commonly associated, while other social determinants showed limited significant associations.
1 citations
,
August 2022 in “Piel” This study found a statistically significant association between dermatological manifestations with vasculonecrotic damage and increased probability of severe COVID-19 disease among patients in Guatemala.
1 citations
,
April 2022 in “Global health & medicine” This review explores long COVID symptoms in Japan and discusses potential contributing factors, highlighting persistent SARS-CoV-2 infection's role, but reports no new clinical results; it also considers vaccination as a treatment option.
1 citations
,
July 2021 in “Organoid (Online)” This review discusses the promise of human organoid technology as an alternative to animal models in drug development, highlighting its growing research and commercial potential.
1 citations
,
January 2021 in “Research Square (Research Square)” This study found that the antiandrogens enzalutamide and bicalutamide reduced SARS-CoV-2 entry and infection in human lung cells by lowering TMPRSS2 levels, suggesting their potential as COVID-19 treatments and supporting clinical trials.
1 citations
,
December 2020 in “Journal of Experimental Biology and Agricultural Sciences” This article reviews the structure, genomic organization, and pathogenesis of SARS-CoV-2 and discusses current efforts in prevention and treatments for COVID-19 without reporting new clinical results.
1 citations
,
September 2020 in “Journal of the Endocrine Society” Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.
1 citations
,
June 2020 in “Dermatologic Therapy” COVID-19 can cause various skin issues, including rashes and 'COVID toes', and may worsen autoimmune diseases or affect men with baldness more severely.
1 citations
,
November 2015 in “Indian Journal of Clinical Biochemistry” The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.
1 citations
,
September 2010 in “The journal of investigative dermatology/Journal of investigative dermatology” This article reviews a variety of research presentations from the Society for Investigative Dermatology's annual meeting, highlighting advances in dermatological research without reporting new clinical results.
August 2026 in “BMC Nephrology” In this study, a young Chinese male with a specific mitochondrial mutation was reported to have proteinuria and renal dysfunction, with stable kidney function after treatment over 23 months.
April 2026 in “Reviews in Medical Virology” This review discusses recent updates on trichodysplasia spinulosa, focusing on its seroepidemiology, mechanisms, and treatment options, and reports no new clinical results.
April 2026 in “Portuguese Journal of Dermatology and Venereology” This review summarizes the various skin manifestations linked to COVID-19 infection, vaccination, and personal protective equipment, highlighting their clinical importance and discussing psychological stress and social isolation as additional dermatologic factors.
This article explores various skin reactions linked to COVID-19, including "COVID toes" and other rashes, which tend to appear in mild cases, while severe conditions like livedo reticularis are more often seen in critically ill patients, according to medical experts.
September 2025 in “Cancer Innovation” This study argues for "clinical trial re-innovation," highlighting new designs like basket, umbrella, and platform trials that incorporate biomarker technologies to meet the dynamic needs of precision medicine, potentially enabling more effective, patient-specific treatments and overcoming limitations of traditional disease-centered trials.
July 2025 in “Cermin Dunia Kedokteran” This study highlights nasopharyngeal carcinoma as the fourth most common cancer in Indonesia, noting that its etiology involves genetic and environmental factors, while early detection often utilizes serology and imaging, with diagnosis confirmed by biopsy and histopathology.
January 2025 in “Drug repurposing” This study reviewed 16 notable drug repurposing patent applications from 2025, highlighting potential new uses such as guanfacine for autonomic dysfunction and disulfiram for subarachnoid hemorrhage survival, though many disclosures lack peer-reviewed studies and no patents are granted.
December 2024 in “Journal of Coloproctology” This study presents a case of a 67-year-old immunocompromised woman with ulcerated genital and perianal lesions diagnosed as herpesvirus-induced dermatovirosis, highlighting the importance of considering viral infections in differential diagnoses and the potential for resistance to typical antiviral treatments.
This study explored new molecular structures as potential COVID-19 treatments, identifying a compound called Hit15 that inhibited viral infection in lab settings and reduced inflammation markers in human neutrophils, suggesting further development is warranted.
Stem cell therapies, especially adipose-derived ones, show promise for treating severe COVID-19 and related conditions.
January 2024 in “Future postharvest and food” This study reviewed the historical and current uses of frankincense, highlighting its potential antiviral, anti-inflammatory, and immunomodulatory effects, particularly noting some clinical evidence that suggests its use in treating COVID-19 symptoms, although more data is needed.
October 2023 in “Microorganisms” This study reported that COVID-19 patients treated with nirmatrelvir/ritonavir had lower anti-spike IgG levels and different cytokine patterns compared to those not receiving antiviral treatment, suggesting early antiviral use may alter immune response by reducing viral load and antigen presentation.
September 2023 in “Zenodo (CERN European Organization for Nuclear Research)” This study examined the clinical and radiological features of lung damage in children caused by COVID-19, highlighting the emergence and persistence of both respiratory and extrapulmonary symptoms in these cases.
August 2023 in “International Journal of Dermatology” This study used a Lebanese national registry to document dermatologic symptoms related to COVID-19 and its vaccines, noting that urticaria and telogen effluvium were common during infection, while urticaria and herpes zoster were notable post-vaccination.
April 2023 in “Media Dermato Venereologica Indonesiana” This case report discusses a new onset of alopecia areata following reinfection with COVID-19, suggesting a potential link between COVID-19 infection and this hair loss condition.
This report details a case of severe alopecia areata developing one month after COVID-19 infection in a 20-year-old woman, suggesting a possible connection between COVID-19 and the condition's onset.